BioScrip starts roadshow for $225 million 5.5-year note offering

By Paul A. Harris

St. Louis, March 9 - BioScrip Inc. began a roadshow on Monday for its $225 million offering of 5.5-year senior notes (B3/B-), according to an informed source.

Jefferies & Co. is the bookrunner for the Rule 144A with registration rights offering.

The notes come with three years of call protection.

Proceeds will be used to help fund the acquisition of Critical Homecare Solutions, as well as to refinance existing debt and for general corporate purposes.

The roadshow wraps up on March 18.

BioScrip is an Elmsford, N.Y.-based specialty pharmaceutical health care organization.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.